MIRA compared with ATLX: revenue, margins and what each company keeps, and the suppliers and customers both name

MIRAMira Pharmaceuticals, Inc.

Mkt capRevenueRevenue

ATLXAtlas Lithium Corp

Mkt capRevenueRevenue

Compare

MIRAMira Pharmaceuticals, Inc.

ATLXAtlas Lithium Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

MIRAMira Pharmaceuticals, Inc.

0.51▼−5.04%· post 0.52

Mkt cap$23.0MRevenue—Revenue—

ATLXAtlas Lithium Corp

1.57▼−0.63%· post 1.60

ClosedNov 3 '26

Mkt cap$47.6MRevenue$74,386Q1 FY26Revenue$667,131FY24

Compare

ClosedNov 3 '26

MIRAMira Pharmaceuticals, Inc.

ATLXAtlas Lithium Corp

0.51▼−5.04%post 0.52

Price

1.57▼−0.63%post 1.60

$23.0M

Mkt cap

$47.6M

—

Revenue

$74,386Q1 FY26

—

Revenue

$667,131FY24

MIRA0.51▼−5.04%vsATLX1.57▼−0.63%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MIRA: latest quarter not drawable. ATLX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: MIRA, ATLX.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

MIRA, solidATLX, dashed